Product NDC: | 54868-5229 |
Proprietary Name: | NEULASTA |
Non Proprietary Name: | pegfilgrastim |
Active Ingredient(s): | 6 mg/.6mL & nbsp; pegfilgrastim |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-5229 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125031 |
Marketing Category: | BLA |
Start Marketing Date: | 20060223 |
Package NDC: | 54868-5229-0 |
Package Description: | 1 BLISTER PACK in 1 BOX (54868-5229-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE |
NDC Code | 54868-5229-0 |
Proprietary Name | NEULASTA |
Package Description | 1 BLISTER PACK in 1 BOX (54868-5229-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE |
Product NDC | 54868-5229 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pegfilgrastim |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20060223 |
Marketing Category Name | BLA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | PEGFILGRASTIM |
Strength Number | 6 |
Strength Unit | mg/.6mL |
Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |